Corpus Intelligence IC Memo — WESTERN ARIZONA REGIONAL MEDICAL CEN 2026-04-26 04:02 UTC
IC Memo — WESTERN ARIZONA REGIONAL MEDICAL CEN
Investment Committee Memorandum | AZ | 93 beds | Grade C | EBITDA uplift $8.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WESTERN ARIZONA REGIONAL MEDICAL CEN

CCN 030101 | MOHAVE, AZ | 93 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WESTERN ARIZONA REGIONAL MEDICAL CEN is a 93-bed community hospital in MOHAVE, AZ with $114.3M in net patient revenue and a 62.0% operating margin. The hospital serves a payer mix of 30.3% Medicare, 0.0% Medicaid, and 69.7% commercial.

Thesis: Turnaround. Our ML models identify $8.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 62.0% to 69.3% (+736bps).

Net Revenue HCRIS$114.3M
Current EBITDA COMPUTED$70.9M
Operating Margin COMPUTED62.0%
Occupancy HCRIS54.0%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS7.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
56
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 62.0% places it above the state median. Among 56 size-comparable peers (46-186 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-186), prioritizing same-state peers. 56 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WESTERN ARIZONA REGIONAL MEDIC (Target)AZ93$114.3M62.0%
BANNER GATEWAY MEDICAL CENTERAZ185$573.8M5.2%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
MOUNTAIN VISTA MEDICAL CENTERAZ162$223.9M-1.0%
BANNER UNIVERSITY MED CENTER SAZ132$190.9M-16.3%
HONORHEALTH SCOTTSDALE THOMPSOAZ120$187.9M-1.6%
VERDE VALLEY MEDICAL CENTERAZ87$172.5M4.3%
BANNER HEART HOSPITALAZ108$162.2M17.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$73K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$73K
Total EBITDA Uplift$8.4M
Current EBITDA$70.9M
+ RCM Uplift+$8.4M
Pro Forma EBITDA$79.3M
Current Margin62.0%
Pro Forma Margin69.3%
WC Released (1x)$4.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$109.0M$551.5M5.06x38.3%
Base (11x exit)10.0x11.0x$109.0M$642.0M5.89x42.6%
Bull Case9.0x11.0x$98.1M$705.2M7.19x48.4%
Bull (12x exit)9.0x12.0x$98.1M$798.3M8.14x52.1%
Bear Case11.0x10.0x$119.9M$474.0M3.95x31.6%
Bear (11x exit)11.0x11.0x$119.9M$560.4M4.67x36.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 56 hospitals with 46-186 beds
  • Same-state prioritization (n=57)
  • Comp margins: P25=-10.9% / P50=-0.8% / P75=6.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.